Afeyan Noubar's Form 4 filing
Moderna, Inc. (MRNA) · filed Jun 11, 2024
- Accession no.
- 0000950170-24-072122
- Filed
- Jun 11, 2024
- Trade date
- Jun 11, 2024
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $30.1M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Afeyan NoubarCIK 0001222012 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2024 | Common Stock | SSaleDisposed | −163,649 | $148.29F1 | −$24,267,510.21 | 7,937,145 | Indirect | |
| Jun 11, 2024 | Common Stock | SSaleDisposed | −31,531 | $148.29F1 | −$4,675,731.99 | 1,529,789 | Indirect | |
| Jun 11, 2024 | Common Stock | SSaleDisposed | −6,420 | $149.40F4 | −$959,148 | 7,930,725 | Indirect | |
| Jun 11, 2024 | Common Stock | SSaleDisposed | −1,232 | $149.40F4 | −$184,060.8 | 1,528,557 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.00 to $148.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Referenced by the price of 2 transactions in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.00 to $149.755, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Referenced by the price of 2 transactions in Table I.